HIMSSCast: The future of telehealth reimbursement
Limitations and uncertainty all around telehealth reimbursement have normally been an impediment to adoption. Through the COVID-19 unexpected emergency, that burden was eased fairly, but now the new regular is starting to choose condition. What barriers nevertheless keep on being to telehealth reimbursement, and how could possibly they be overcome? To response that issue, host Jonah Comstock and Health care Finance News Managing Editor Susan Morse welcome McKinsey & Company associates Oleg Bestsennyy and Gunjan Khanna.
This episode is brought to you by BlueJeans.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Participate in!
Conversing details:
- COVID-19 reimbursement improvements and which of them will adhere all around
- Adoption classes uncovered and how they’ll impact reimbursement coverage
- Holistic tele-treatment and treatment past the movie check out
- Influence of new entrants and innovation on the house
- Is price-for-provider reimbursement an innovation blocker?
- Reimbursement for unique telehealth modalities
- Time to direct relatively than stick to for personal payers?
- The nevertheless-unresolved issue of induced utilization
- The increase of worth-dependent treatment and hybrid treatment types
- Telehealth reimbursement and wellbeing fairness
- How are individuals sensation about telehealth now?
- Final thoughts: the long run of telehealth reimbursement
More about this episode:
Report shows ‘vast improvement’ in point out telehealth reimbursement procedures
COVID-19 might forever alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurance provider concerns of overutilization
CMS will reimburse for eleven new telehealth products and services for the duration of the public wellbeing unexpected emergency
Congressional motion is needed for telehealth not to return to a rural advantage, Seema Verma claims
Telehealth: A quarter-trillion-greenback submit-COVID-19 actuality? (McKinsey)
COVID-19 Consumer Health care Insights: What 2021 might hold (McKinsey)
How COVID-19 has adjusted the way US buyers assume about healthcare (McKinsey)
